You are viewing the site in preview mode
Skip to main content
|
References
|
Host country(ies)
|
Sample size
|
Species
|
IBD model, chronicity
|
Age (weeks)
|
Biological sex (M/F)
|
|---|
|
Araki et al. [41]
|
Japan
|
40
|
Rats
|
DSS-induced, NR
|
12
|
M
|
|
Araki et al. [29]
|
Japan
|
18
|
Rats
|
DSS-induced, NR
|
11
|
M
|
|
Bassaganya-Riera et al. [34]
|
USA
|
275
|
Mice
|
IL-10 knockout, NR
|
8
|
50:50, M/F
|
|
Islam et al. [27]
|
Japan
|
24
|
Mice
|
DSS-induced, acute
|
10–12
|
M
|
|
Jacobasch et al. [36]
|
Germany
|
NR
|
Rats
|
TNBS-induced, NR
|
NR
|
NR
|
|
Kanauchi et al. [39, 40]
|
Japan
|
8
|
Rats
|
DSS-induced, acute
|
NR
|
M
|
|
Kanauchi et al. [39, 40]
|
Japan
|
8
|
Rats
|
DSS-induced, chronic
|
NR
|
M
|
|
Kanauchi et al. [38, 45]
|
Japan
|
20
|
Mice
|
DSS induced, acute
|
9
|
F
|
|
Kanauchi et al. [35]
|
Japan
|
16
|
Mice
|
CD4+ CD45RB T cell transfer, chronic
|
5
|
F
|
|
Komiyama et al. [32]
|
Japan
|
30
|
Mice
|
DSS-induced, acute
|
9
|
F
|
|
Le Leu et al. [15]
|
Australia
|
32
|
Mice
|
DSS-induced, acute
|
NR
|
M
|
|
Majumder et al. [28]
|
Canada & Japan
|
24
|
Mice
|
DSS-induced, acute
|
6–8
|
F
|
|
Moreau et al. [17]
|
France
|
72
|
Rats
|
DSS-induced, chronic
|
NR
|
M
|
|
Moreau et al. [37]
|
France
|
60
|
Rats
|
DSS-induced, acute and chronic
|
NR
|
M
|
|
Morita et al. [16]
|
Japan
|
32
|
Rats
|
TNBS-induced, acute
|
NR
|
M
|
|
Panasevich et al. [26]
|
USA
|
66
|
Mice
|
DSS-induced, acute
|
8–10
|
M
|
|
Praengam et al. [25]
|
Thailand
|
32
|
Mice
|
DSS-induced, acute
|
6
|
F
|
|
Qian et al. [30]
|
China
|
40
|
Mice
|
DSS-induced, acute
|
7
|
F
|
|
Rodriguez-Cabezas et al. [33]
|
Spain
|
50
|
Rats
|
TNBS-induced, acute
|
NR
|
F
|
|
Scarminio et al. [31]
|
Brazil
|
72
|
Rats
|
TNBS-induced, acute
|
NR
|
M
|
|
Shinde et al. [42]
|
Australia
|
50
|
Mice
|
DSS-induced, acute
|
7
|
Both
|
- DSS dextran sulfate sodium, F female, M male, NR not reported, SCID severe combined immunodeficiency, TNBS trinitrobenzene sulfonic acid